Use of 1,25(OH)2-vitamin D3 in prevention of renal osteodystrophy: preliminary observations. 1980

L R Baker, and J W Muir, and W R Cattell, and K A Tucker, and V L Sharman, and F J Goodwin, and F P Marsh, and W Hately, and A G Morgan, and D M de Saintonge

Hypercalcaemia regularly occurs when "prophylactic" 1,25-dihydroxyvitamin D3 (1,25[OH)2D3) in a dose of 1.0 microgram daily is given to haemodialysis patients without clinical biochemical or radiological evidence of osteodystophy. This dose is too large for such patients. Hypercalcaemia may persist for several weeks after withdrawal of 1,25(OH)2D3, particularly when previous attempts at control by dosage reduction have failed. Hypercalcaemia is better managed by stopping 1,25(OH)2D3, albeit temporarily, than by reducing the dose.

UI MeSH Term Description Entries
D007690 Polycystic Kidney Diseases Hereditary diseases that are characterized by the progressive expansion of a large number of tightly packed CYSTS within the KIDNEYS. They include diseases with autosomal dominant and autosomal recessive inheritance. Kidney, Polycystic,Polycystic Kidney,Polycystic Kidney Disease,Polycystic Kidneys,Polycystic Renal Disease,Disease, Polycystic Kidney,Disease, Polycystic Renal,Diseases, Polycystic Kidney,Diseases, Polycystic Renal,Kidney Disease, Polycystic,Kidney Diseases, Polycystic,Kidneys, Polycystic,Polycystic Renal Diseases,Renal Disease, Polycystic,Renal Diseases, Polycystic
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D012080 Chronic Kidney Disease-Mineral and Bone Disorder Decalcification of bone or abnormal bone development due to chronic KIDNEY DISEASES, in which 1,25-DIHYDROXYVITAMIN D3 synthesis by the kidneys is impaired, leading to reduced negative feedback on PARATHYROID HORMONE. The resulting SECONDARY HYPERPARATHYROIDISM eventually leads to bone disorders. Renal Osteodystrophy,Renal Rickets,Rickets, Renal,CKD-MBD,Osteodystrophy, Renal,Chronic Kidney Disease Mineral and Bone Disorder,Osteodystrophies, Renal,Renal Osteodystrophies
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D004100 Dihydroxycholecalciferols Cholecalciferols substituted with two hydroxy groups in any position. Dihydroxyvitamins D
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006887 Hydroxycholecalciferols Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3. Hydroxyvitamins D,Hydroxycholecalciferol

Related Publications

L R Baker, and J W Muir, and W R Cattell, and K A Tucker, and V L Sharman, and F J Goodwin, and F P Marsh, and W Hately, and A G Morgan, and D M de Saintonge
January 1977, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
L R Baker, and J W Muir, and W R Cattell, and K A Tucker, and V L Sharman, and F J Goodwin, and F P Marsh, and W Hately, and A G Morgan, and D M de Saintonge
January 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
L R Baker, and J W Muir, and W R Cattell, and K A Tucker, and V L Sharman, and F J Goodwin, and F P Marsh, and W Hately, and A G Morgan, and D M de Saintonge
April 1999, Der Internist,
L R Baker, and J W Muir, and W R Cattell, and K A Tucker, and V L Sharman, and F J Goodwin, and F P Marsh, and W Hately, and A G Morgan, and D M de Saintonge
January 1982, The Quarterly journal of medicine,
L R Baker, and J W Muir, and W R Cattell, and K A Tucker, and V L Sharman, and F J Goodwin, and F P Marsh, and W Hately, and A G Morgan, and D M de Saintonge
August 1987, British journal of haematology,
L R Baker, and J W Muir, and W R Cattell, and K A Tucker, and V L Sharman, and F J Goodwin, and F P Marsh, and W Hately, and A G Morgan, and D M de Saintonge
January 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
L R Baker, and J W Muir, and W R Cattell, and K A Tucker, and V L Sharman, and F J Goodwin, and F P Marsh, and W Hately, and A G Morgan, and D M de Saintonge
February 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
L R Baker, and J W Muir, and W R Cattell, and K A Tucker, and V L Sharman, and F J Goodwin, and F P Marsh, and W Hately, and A G Morgan, and D M de Saintonge
November 1978, Nature,
L R Baker, and J W Muir, and W R Cattell, and K A Tucker, and V L Sharman, and F J Goodwin, and F P Marsh, and W Hately, and A G Morgan, and D M de Saintonge
October 1998, Steroids,
L R Baker, and J W Muir, and W R Cattell, and K A Tucker, and V L Sharman, and F J Goodwin, and F P Marsh, and W Hately, and A G Morgan, and D M de Saintonge
January 1999, International journal of clinical pharmacology research,
Copied contents to your clipboard!